Decoding the dark genome reveals its organisation into modular disease networks.

Area of Science:

• Genomics
• Systems Biology
• Human Genetics

Background:

• The 'dark genome,' comprising over a third of protein-coding genes, has largely unknown biological functions and disease relevance.
• Understanding these genes is crucial for advancing human health and disease research.

Purpose of the Study:

• To construct a systems-level map of dark gene contributions to human genetic diseases.
• To identify key dark genes and their functional roles in disease networks.
• To reveal the regulatory mechanisms and therapeutic potential of the dark genome.

Main Methods:

• Integrative network and functional analyses were employed.
• Identification of hub dark genes and their network centrality.
• Analysis of gene expression regulation by genetic variants (eQTLs).

Main Results:

• Identified 16 hub dark genes, including R3HDM2 and RPUSD4, central to disease networks.
• These hubs are enriched for roles in mitochondrial protein synthesis and connect inflammatory diseases.
• Tissue-specific expression is controlled by thousands of eQTLs, linking them to phenotypes like myocardial infarction and diabetes.

Conclusions:

• The dark genome plays a critical role in mitochondrial pathways and human diseases.
• Identified novel therapeutic targets within the dark genome.
• Provides a functional landscape for previously uncharacterized genes.